APA (7th ed.) Citation

Dudek, A. Z., Liu, L. C., Fischer, J. H., Wiley, E. L., Sachdev, J. C., Bleeker, J., . . . O’Regan, R. M. (2020). Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy. Breast cancer research and treatment, 183(3), 617-627. https://doi.org/10.1007/s10549-020-05787-z

Chicago Style (17th ed.) Citation

Dudek, Arkadiusz Z., et al. "Phase 1 Study of TTC-352 in Patients with Metastatic Breast Cancer Progressing on Endocrine and CDK4/6 Inhibitor Therapy." Breast Cancer Research and Treatment 183, no. 3 (2020): 617-627. https://doi.org/10.1007/s10549-020-05787-z.

MLA (9th ed.) Citation

Dudek, Arkadiusz Z., et al. "Phase 1 Study of TTC-352 in Patients with Metastatic Breast Cancer Progressing on Endocrine and CDK4/6 Inhibitor Therapy." Breast Cancer Research and Treatment, vol. 183, no. 3, 2020, pp. 617-627, https://doi.org/10.1007/s10549-020-05787-z.